Literature DB >> 24973868

Patient-reported quality-of-life and sexual-function outcomes after laparoscopic supracervical hysterectomy (LSH) versus total laparoscopic hysterectomy (TLH): a prospective, questionnaire-based follow-up study in 915 patients.

Sara Y Brucker1, Florin-Andrei Taran, Sandra Bogdanyova, Sandra Ebersoll, Christian W Wallwiener, Birgitt Schönfisch, Bernhard Krämer, Harald Abele, Felix Neis, Christof Sohn, Stephanie Gawlik, Diethelm Wallwiener, Markus Wallwiener.   

Abstract

PURPOSE: To compare patient-reported quality-of-life and sexual function outcomes in women after laparoscopic supracervical hysterectomy (LSH) or total laparoscopic hysterectomy (TLH) for benign uterine disease.
METHODS: Out of a cohort of 1,952 patients from a previous implementation study of LSH and TLH, 1,886 patients who had not undergone intraoperative conversion to laparotomy or were ineligible for other reasons were invited by mail to participate in this prospective, questionnaire-based follow-up study.
RESULTS: Of the 915/1,952 (48.5 %) survey respondents included in the analysis, 788 (86.1 %) and 127 (13.9 %) had undergone LSH or TLH, respectively. Women undergoing LSH reported significantly lower pain levels (p = 0.037) and faster partial (p = 0.015) and complete (p < 0.001) resumption of normal daily activities compared to those undergoing TLH. As regards sexual function, women undergoing LSH resumed sexual activity significantly sooner (p = 0.018), rated sexual desire as higher (p = 0.023), and reported more frequently that their sexual life had improved postoperatively (p = 0.008) than did women undergoing TLH.
CONCLUSIONS: Women undergoing LSH for benign uterine disease may have better outcomes regarding certain quality-of-life and sexual function parameters than women undergoing TLH for benign uterine disease.

Entities:  

Mesh:

Year:  2014        PMID: 24973868     DOI: 10.1007/s00404-014-3318-1

Source DB:  PubMed          Journal:  Arch Gynecol Obstet        ISSN: 0932-0067            Impact factor:   2.344


  7 in total

1.  The influence of conventional and extended supracervical hysterectomy on sexuality and quality of life parameters: a prospective bi-center study with a special focus on postoperative spotting.

Authors:  C Spüntrup; M Banerjee; M Bordelius; M Hellmich; J Bojahr; B Bojahr; C Albus; G Noé
Journal:  Arch Gynecol Obstet       Date:  2022-01-10       Impact factor: 2.344

Review 2.  Hysterectomy for Benign Uterine Disease.

Authors:  Klaus J Neis; Wolfgang Zubke; Mathias Fehr; Thomas Römer; Karl Tamussino; Monika Nothacker
Journal:  Dtsch Arztebl Int       Date:  2016-04-08       Impact factor: 5.594

Review 3.  Effects of Hysterectomy on Sexual Function.

Authors:  Risa Lonnée-Hoffmann; Ingrid Pinas
Journal:  Curr Sex Health Rep       Date:  2014

4.  Retrospective analysis of secondary resection of the cervical stump after subtotal hysterectomy: why and when?

Authors:  Felix Neis; Christl Reisenauer; Bernhard Kraemer; Philipp Wagner; Sara Brucker
Journal:  Arch Gynecol Obstet       Date:  2021-08-28       Impact factor: 2.344

5.  Cervical stump necrosis after laparoscopic supracervical hysterectomy: successful management by laparoscopic approach.

Authors:  Xin Le; Nasuh Utku Dogan; Giovanni Favero; Christhardt Köhler
Journal:  J Int Med Res       Date:  2021-06       Impact factor: 1.671

6.  Trans-Mucosal Efficacy of Non-Thermal Plasma Treatment on Cervical Cancer Tissue and Human Cervix Uteri by a Next Generation Electrosurgical Argon Plasma Device.

Authors:  Thomas Wenzel; Daniel A Carvajal Berrio; Christl Reisenauer; Shannon Layland; André Koch; Diethelm Wallwiener; Sara Y Brucker; Katja Schenke-Layland; Eva-Maria Brauchle; Martin Weiss
Journal:  Cancers (Basel)       Date:  2020-01-22       Impact factor: 6.639

7.  Identifying What Matters to Hysterectomy Patients: Postsurgery Perceptions, Beliefs, and Experiences.

Authors:  Andrew S Bossick; Roopina Sangha; Heather Olden; Gwen L Alexander; Ganesa Wegienka
Journal:  J Patient Cent Res Rev       Date:  2018-04-26
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.